Search hospitals > Maryland > Rosedale
MedStar Franklin Square Medical Center/Weinberg Cancer Institute
Claim this profileRosedale, Maryland 21237
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Ovarian Cancer
Conducts research for Breast cancer
Conducts research for Uterine Cancer
107 reported clinical trials
19 medical researchers
Summary
MedStar Franklin Square Medical Center/Weinberg Cancer Institute is a medical facility located in Rosedale, Maryland. This center is recognized for care of Breast Cancer, Lung Cancer, Ovarian Cancer, Breast cancer, Uterine Cancer and other specialties. MedStar Franklin Square Medical Center/Weinberg Cancer Institute is involved with conducting 107 clinical trials across 188 conditions. There are 19 research doctors associated with this hospital, such as Anteneh A. Tesfaye, Benjamin A. Weinberg, Stephen V. Liu, and Chul Kim.Area of expertise
1Breast Cancer
Global LeaderER positive
HER2 negative
HER2 positive
2Lung Cancer
Global LeaderStage II
Stage I
Stage III
Top PIs
Anteneh A. TesfayeWayne State University/Karmanos Cancer Institute6 years of reported clinical research
Studies Colorectal Cancer
Studies Colon Cancer
19 reported clinical trials
39 drugs studied
Benjamin A. WeinbergMedStar Georgetown University Hospital1 year of reported clinical research
Studies Pancreatic Cancer
Studies Colon Cancer
17 reported clinical trials
35 drugs studied
Stephen V. LiuMedStar Georgetown University Hospital8 years of reported clinical research
Expert in Lung Cancer
Studies Non-Small Cell Lung Cancer
16 reported clinical trials
29 drugs studied
Chul KimMedStar Georgetown University Hospital3 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
11 reported clinical trials
17 drugs studied
Clinical Trials running at MedStar Franklin Square Medical Center/Weinberg Cancer Institute
Lung Cancer
Breast Cancer
Uterine Cancer
Cutaneous Melanoma
Melanoma
Non-Small Cell Lung Cancer
Bladder Cancer
Breast cancer
Colorectal Cancer
Prostate Cancer
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Treatment Timing
for Non-Small Cell Lung Cancer
This phase III trial compares standard therapy given after surgery (adjuvant) to standard therapy given before and after surgery (perioperative) in treating patients with stage II-IIIB non-small cell lung cancer (NSCLC) that can be removed by surgery (resectable). The usual approach for patients with resectable NSCLC is chemotherapy and/or immunotherapy before surgery, after surgery, or both before and after surgery. This study is being done to find out which approach is better at treating patients with lung cancer. Treatment will be administered according to the current standard of care at the time of enrollment. Chemotherapy options may include cisplatin, carboplatin, pemetrexed, gemcitabine, docetaxel, and vinorelbine at standard doses according to the treating physician. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of tumor cells. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Pemetrexed is in a class of medications called antifolate antineoplastic agents. It works by stopping cells from using folic acid to make deoxyribonucleic acid (DNA) and may kill tumor cells. Gemcitabine is a chemotherapy drug that blocks the cells from making DNA and may kill tumor cells. Docetaxel is in a class of medications called taxanes. It stops tumor cells from growing and dividing and may kill them. Other chemotherapy drugs, such as vinorelbine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading . Immunotherapy with monoclonal antibodies, such as nivolumab, pembrolizumab, and atezolizumab, may help the body's immune system attack the tumor, and may interfere with the ability of tumor cells to grow and spread. Starting treatment with chemotherapy and immunotherapy prior to surgery and continuing treatment after surgery may be a more effective treatment option than adjuvant therapy alone in patients with stage II-IIIB resectable NSCLC.
Recruiting2 awards Phase 34 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at MedStar Franklin Square Medical Center/Weinberg Cancer Institute?
MedStar Franklin Square Medical Center/Weinberg Cancer Institute is a medical facility located in Rosedale, Maryland. This center is recognized for care of Breast Cancer, Lung Cancer, Ovarian Cancer, Breast cancer, Uterine Cancer and other specialties. MedStar Franklin Square Medical Center/Weinberg Cancer Institute is involved with conducting 107 clinical trials across 188 conditions. There are 19 research doctors associated with this hospital, such as Anteneh A. Tesfaye, Benjamin A. Weinberg, Stephen V. Liu, and Chul Kim.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.